Isamu Okamoto

机构：Kyushu University, Kyushu University Hospital · ORCID：0000-0002-7587-6096

发表论文 787 篇 · 总被引 34249 次 · h-index 77

代表论文

• A Multicenter Randomized Phase III Trial Comparing MET Tyrosine Kinase Inhibitors vs. Immune Checkpoint Inhibitors With or Without Chemotherapy as First-Line Treatment for Patients With Advanced Non–Small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutations: JCOG2506 (DECIDE-MET) (2026 · Clinical Lung Cancer)
• Daily low-dose carboplatin or weekly carboplatin plus nab-paclitaxel for concurrent chemoradiotherapy in older patients with locally advanced non-small cell lung cancer (JCOG1914): A randomized phase 3 trial (2026 · Lung Cancer)
• Supplementary Figure S5 from Incidence of B-cell Malignancies in Patients with Lung Cancer Receiving PD-1 Blockade Therapy (2026)
• Supplementary Figure S13 from Incidence of B-cell Malignancies in Patients with Lung Cancer Receiving PD-1 Blockade Therapy (2026)
• Supplementary Figure S15 from Incidence of B-cell Malignancies in Patients with Lung Cancer Receiving PD-1 Blockade Therapy (2026)
• Supplementary Table S3 from Incidence of B-cell Malignancies in Patients with Lung Cancer Receiving PD-1 Blockade Therapy (2026)